|
1
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shackleton M, Quintana E, Fearon ER and
Morrison SJ: Heterogeneity in cancer: Cancer stem cells versus
clonal evolution. Cell. 138:822–829. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sottoriva A, Verhoeff JJ, Borovski T,
McWeeney SK, Naumov L, Medema JP, Sloot PM and Vermeulen L: Cancer
stem cell tumor model reveals invasive morphology and increased
phenotypical heterogeneity. Cancer Res. 70:46–56. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ginestier C, Hur MH, Charafe-Jauffret E,
Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG,
Liu S, et al: ALDH1 is a marker of normal and malignant human
mammary stem cells and a predictor of poor clinical outcome. Cell
Stem Cell. 1:555–567. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Morimoto K, Kim SJ, Tanei T, Shimazu K,
Tanji Y, Taguchi T, Tamaki Y, Terada N and Noguchi S: Stem cell
marker aldehyde dehydrogenase 1-positive breast cancers are
characterized by negative estrogen receptor, positive human
epidermal growth factor receptor type 2, and high Ki67 expression.
Cancer Sci. 100:1062–1068. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Deng S, Yang X, Lassus H, Liang S, Kaur S,
Ye Q, Li C, Wang LP, Roby KF, Orsulic S, et al: Distinct expression
levels and patterns of stem cell marker, aldehyde dehydrogenase
isoform 1 (ALDH1), in human epithelial cancers. PLoS One.
5:e102772010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Croker AK, Goodale D, Chu J, Postenka C,
Hedley BD, Hess DA and Allan AL: High aldehyde dehydrogenase and
expression of cancer stem cell markers selects for breast cancer
cells with enhanced malignant and metastatic ability. J Cell Mol
Med. 13:2236–2252. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wicha MS, Liu S and Dontu G: Cancer stem
cells: An old idea-a paradigm shift. Cancer Res. 66:1883–1890;
discussion 1895–1896. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Stingl J, Eirew P, Ricketson I, Shackleton
M, Vaillant F, Choi D, Li HI and Eaves CJ: Purification and unique
properties of mammary epithelial stem cells. Nature. 439:993–997.
2006.PubMed/NCBI
|
|
10
|
Dontu G, Abdallah WM, Foley JM, Jackson
KW, Clarke MF, Kawamura MJ and Wicha MS: In vitro propagation and
transcriptional profiling of human mammary stem/progenitor cells.
Genes Dev. 17:1253–1270. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA.
100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bane A, Viloria-Petit A, Pinnaduwage D,
Mulligan AM, O'Malley FP and Andrulis IL: Clinical-pathologic
significance of cancer stem cell marker expression in familial
breast cancers. Breast Cancer Res Treat. 140:195–205. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer, and cancer stem cells. Nature.
414:105–111. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ponti D, Costa A, Zaffaroni N, Pratesi G,
Petrangolini G, Coradini D, Pilotti S, Pierotti MA and Daidone MG:
Isolation and in vitro propagation of tumorigenic breast cancer
cells with stem/progenitor cell properties. Cancer Res.
65:5506–5511. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hwang-Verslues WW, Kuo WH, Chang PH, Pan
CC, Wang HH, Tsai ST, Jeng YM, Shew JY, Kung JT, Chen CH, et al:
Multiple lineages of human breast cancer stem/progenitor cells
identified by profiling with stem cell markers. PLoS One.
4:e83772009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Phillips TM, McBride WH and Pajonk F: The
response of CD24(−/low)/CD44+ breast cancer-initiating cells to
radiation. J Natl Cancer Inst. 98:1777–1785. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dey D, Saxena M, Paranjape AN, Krishnan V,
Giraddi R, Kumar MV, Mukherjee G and Rangarajan A: Phenotypic and
functional characterization of human mammary stem/progenitor cells
in long term culture. PLoS One. 4:e53292009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ueda K, Ogasawara S, Akiba J, Nakayama M,
Todoroki K, Ueda K, Sanada S, Suekane S, Noguchi M, Matsuoka K and
Yano H: Aldehyde dehydrogenase 1 identifies cells with cancer stem
cell-like properties in a human renal cell carcinoma cell line.
PLoS One. 8:e754632013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rasper M, Schäfer A, Piontek G, Teufel J,
Brockhoff G, Ringel F, Heindl S, Zimmer C and Schlegel J: Aldehyde
dehydrogenase 1 positive glioblastoma cells show brain tumor stem
cell capacity. Neuro Oncol. 12:1024–1033. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mieog JS, de Kruijf EM, Bastiaannet E,
Kuppen PJ, Sajet A, de Craen AJ, Smit VT, van de Velde CJ and
Liefers GJ: Age determines the prognostic role of the cancer stem
cell marker aldehyde dehydrogenase-1 in breast cancer. BMC Cancer.
12:422012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kuroda T, Hirohashi Y, Torigoe T, Yasuda
K, Takahashi A, Asanuma H, Morita R, Mariya T, Asano T, Mizuuchi M,
et al: ALDH1-high ovarian cancer stem-like cells can be isolated
from serous and clear cell adenocarcinoma cells and ALDH1 high
expression is associated with poor prognosis. PLoS One.
8:e651582013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lohberger B, Rinner B, Stuendl N, Absenger
M, Liegl-Atzwanger B, Walzer SM, Windhager R and Leithner A:
Aldehyde dehydrogenase 1, a potential marker for cancer stem cells
in human sarcoma. PLoS One. 7:e436642012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Krause U, Ryan DM, Clough BH and Gregory
CA: An unexpected role for a Wnt-inhibitor: Dickkopf-1 triggers a
novel cancer survival mechanism through modulation of
aldehyde-dehydrogenase-1 activity. Cell Death Dis. 5:e10932014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lohberger B, Stuendl N, Wolf E,
Liegl-Atzwanger B, Leithner A and Rinner B: The novel
myxofibrosarcoma cell line MUG-Myx1 expresses a tumourigenic
stem-like cell population with high aldehyde dehydrogenase 1
activity. BMC Cancer. 13:5632013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wegman-Points LJ, Teoh-Fitzgerald ML, Mao
G, Zhu Y, Fath MA, Spitz DR and Domann FE: Retroviral-infection
increases tumorigenic potential of MDA-MB-231 breast carcinoma
cells by expanding an aldehyde dehydrogenase (ALDH1) positive
stem-cell like population. Redox Biol. 2:847–854. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kim YS, Jung MJ, Ryu DW and Lee CH:
Clinicopathologic characteristics of breast cancer stem cells
identified on the basis of aldehyde dehydrogenase 1 expression. J
Breast Cancer. 17:121–128. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhou W, Yang Y, Gu Z, Wang H, Xia J, Wu X,
Zhan X, Levasseur D, Zhou Y, Janz S, et al: ALDH1 activity
identifies tumor-initiating cells and links to chromosomal
instability signatures in multiple myeloma. Leukemia. 28:1155–1158.
2014. View Article : Google Scholar : PubMed/NCBI
|
